Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (21-30 of 528) with videos related to

Pageof 53
Sort By:
Clinical Lung Cancer|August 22, 2021
Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung AdenocarcinomaRanjan Pathak, Ravi Salgia
Cell Reports. Medicine|February 28, 2025
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancerMartin Sattler, Ravi Salgia
Journal of Clinical Medicine|August 12, 2023
On the Virtues of "Team Medicine"-A City of Hope PerspectivePrakash Kulkarni, Ravi Salgia
Iscience|March 14, 2024
Comprehending phenotypic plasticity in cancer and evolutionPrakash Kulkarni, Ravi Salgia
Seminars in Oncology|March 14, 2003
Molecular and cellular biology of small cell lung cancerMartin Sattler, Ravi Salgia
Biomarkers in Medicine|October 6, 2009
Biomarkers in lung cancer: from early detection to novel therapeutics and decision makingApril Scott, Ravi Salgia
Leukemia Research|March 24, 2004
Targeting c-Kit mutations: basic science to novel therapiesMartin Sattler, Ravi Salgia
Current Oncology Reports|February 10, 2007
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapyMartin Sattler, Ravi Salgia
Journal of Clinical Medicine|September 18, 2020
Integrating Clinical and Translational Research Networks-Building Team MedicineRavi Salgia, Prakash Kulkarni
Science Translational Medicine|October 25, 2013
A new hope for precision medicineRavi Salgia, Martin Sattler
Pageof 53

Showing results (21-30 of 528) with videos related to

Sort By:
Pageof 53
Clinical Lung Cancer|August 22, 2021
Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung AdenocarcinomaRanjan Pathak, Ravi Salgia
Cell Reports. Medicine|February 28, 2025
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancerMartin Sattler, Ravi Salgia
Journal of Clinical Medicine|August 12, 2023
On the Virtues of "Team Medicine"-A City of Hope PerspectivePrakash Kulkarni, Ravi Salgia
Iscience|March 14, 2024
Comprehending phenotypic plasticity in cancer and evolutionPrakash Kulkarni, Ravi Salgia
Seminars in Oncology|March 14, 2003
Molecular and cellular biology of small cell lung cancerMartin Sattler, Ravi Salgia
Biomarkers in Medicine|October 6, 2009
Biomarkers in lung cancer: from early detection to novel therapeutics and decision makingApril Scott, Ravi Salgia
Leukemia Research|March 24, 2004
Targeting c-Kit mutations: basic science to novel therapiesMartin Sattler, Ravi Salgia
Current Oncology Reports|February 10, 2007
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapyMartin Sattler, Ravi Salgia
Journal of Clinical Medicine|September 18, 2020
Integrating Clinical and Translational Research Networks-Building Team MedicineRavi Salgia, Prakash Kulkarni
Science Translational Medicine|October 25, 2013
A new hope for precision medicineRavi Salgia, Martin Sattler
Pageof 53